Hologic Inc (HOLX) - Total Liabilities
Based on the latest financial reports, Hologic Inc (HOLX) has total liabilities worth $3.94 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Hologic Inc generate cash to assess how effectively this company generates cash.
Hologic Inc - Total Liabilities Trend (1989–2025)
This chart illustrates how Hologic Inc's total liabilities have evolved over time, based on quarterly financial data. Check Hologic Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Hologic Inc Competitors by Total Liabilities
The table below lists competitors of Hologic Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yum China Holdings Inc
NYSE:YUMC
|
USA | $4.65 Billion |
|
Rentokil Initial PLC
NYSE:RTO
|
USA | $8.93 Billion |
|
Lundin Gold Inc
TO:LUG
|
Canada | CA$316.25 Million |
|
Banco Bradesco S.A.
SA:BBDC3
|
Brazil | R$2.15 Trillion |
|
BE SEMICON.INDS NY EO091
F:BSIA
|
Germany | €697.35 Million |
|
Brookfield Infrastructure Partners L.P
TO:BIP-UN
|
Canada | CA$92.61 Billion |
|
Bank Polska Kasa Opieki SA
WAR:PEO
|
Poland | zł316.87 Billion |
Liability Composition Analysis (1989–2025)
This chart breaks down Hologic Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hologic Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hologic Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hologic Inc (1989–2025)
The table below shows the annual total liabilities of Hologic Inc from 1989 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $3.97 Billion | -1.47% |
| 2024-09-30 | $4.03 Billion | -2.34% |
| 2023-09-30 | $4.12 Billion | -1.73% |
| 2022-09-30 | $4.20 Billion | -10.77% |
| 2021-09-30 | $4.70 Billion | +4.74% |
| 2020-09-30 | $4.49 Billion | +3.61% |
| 2019-09-30 | $4.33 Billion | -9.79% |
| 2018-09-30 | $4.80 Billion | -7.56% |
| 2017-09-30 | $5.19 Billion | +0.40% |
| 2016-09-30 | $5.17 Billion | -7.45% |
| 2015-09-30 | $5.59 Billion | -11.98% |
| 2014-09-30 | $6.35 Billion | -10.02% |
| 2013-09-30 | $7.06 Billion | -6.08% |
| 2012-09-30 | $7.52 Billion | +144.67% |
| 2011-09-30 | $3.07 Billion | +4.94% |
| 2010-09-30 | $2.93 Billion | -7.86% |
| 2009-09-30 | $3.18 Billion | -9.03% |
| 2008-09-30 | $3.49 Billion | +1239.99% |
| 2007-09-30 | $260.63 Million | +4.06% |
| 2006-09-30 | $250.46 Million | +303.93% |
| 2005-09-30 | $62.01 Million | +36.35% |
| 2004-09-30 | $45.48 Million | +14.62% |
| 2003-09-30 | $39.68 Million | -5.23% |
| 2002-09-30 | $41.87 Million | -49.75% |
| 2001-09-30 | $83.31 Million | -5.42% |
| 2000-09-30 | $88.08 Million | +246.78% |
| 1999-09-30 | $25.40 Million | -21.12% |
| 1998-09-30 | $32.20 Million | +79.89% |
| 1997-09-30 | $17.90 Million | +13.29% |
| 1996-09-30 | $15.80 Million | +41.07% |
| 1995-09-30 | $11.20 Million | +30.23% |
| 1994-09-30 | $8.60 Million | +45.76% |
| 1993-09-30 | $5.90 Million | +28.26% |
| 1992-09-30 | $4.60 Million | +48.39% |
| 1991-09-30 | $3.10 Million | -32.61% |
| 1990-09-30 | $4.60 Million | -13.21% |
| 1989-09-30 | $5.30 Million | -- |
About Hologic Inc
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms… Read more